CJC-1295 (No DAC)/IPAMORELIN BLEND
Price range: $85.99 through $816.90
CJC-1295 (No DAC)/Ipamorelin Blend is a synergistic wellness formulation designed to support natural recovery cycles, lean body support, and overall vitality. By combining two complementary peptides, this blend works with the body’s natural rhythms to promote balance, performance, and consistency.
PRODUCT OVERIVEW
CJC-1295 (No DAC) / Ipamorelin is a synthetic peptide blend composed of a growth hormone–releasing hormone (GHRH) analogue and a selective ghrelin receptor agonist. It has been extensively studied for its interaction with GHRH receptors and growth hormone secretagogue receptors (GHS-R1a), which are associated with growth hormone release, metabolic regulation, and endocrine signaling. CJC-1295 (No DAC) / Ipamorelin is notable for its ability to influence central endocrine pathways rather than acting through direct exogenous hormone replacement.
KEY FEATURES THAT MAKES CJC-1295 (No DAC)/IPAMORELIN BLEND STAND OUT
- Synthetic growth hormone–releasing hormone analogue.
- Selective ghrelin receptor (GHS-R1a) agonist.
- Centrally mediated endocrine mechanism of action.
- Short-acting (No DAC) formulation supporting pulsatile signaling.
- Derived from well-characterized peptide frameworks.
- Supported by both preclinical and clinical research.
CHEMIAL MARKUP
Peptide Name: CJC-1295 (No DAC) / Ipamorelin Blend
CJC-1295 (No DAC) Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Ipamorelin Molecular Formula: C₃₈H₄₉N₉O₅
CJC-1295 (No DAC) Molecular Weight: ~3367.9 g/mol
Ipamorelin Molecular Weight: ~711.9 g/mol
Peptide Class: Growth hormone secretagogues
RESEARCH & CLINICAL STUDIES
Early studies explored CJC-1295 (No DAC) / Ipamorelin’s effects on growth hormone release dynamics in animal and in-vitro models, particularly focusing on pulsatile secretion patterns and endocrine responsiveness. Research findings suggested enhanced growth hormone release without prolonged elevation, indicating a regulated endocrine mechanism rather than nonspecific hormonal stimulation. Researchers concluded that this peptide blend may influence central growth hormone signaling pathways involved in metabolic and recovery-related processes.
SAFETY AND TOLERABIITY
CJC-1295 (No DAC) / Ipamorelin demonstrated a predictable tolerability profile when evaluated under controlled conditions. Reported responses were generally dose-dependent and transient. No long-term adverse endocrine or neurological outcomes were identified within the scope of available studies.
NOTES
- For Research Use Only
- Not for use in humans or animals.
- Not for diagnostic or therapeutic purposes.
How to Use:
In laboratory research, the lyophilized peptide blend is reconstituted with sterile or bacteriostatic water and administered via controlled subcutaneous injection per experimental protocol, with dose and frequency defined by study design.
Common Side Effects:
In research settings and anecdotal reports, common mild effects include water retention, headaches, flushing and injection‑site irritation, with effects generally transient; detailed safety profiles in humans are limited.
Who Should Avoid:
This blend is intended for laboratory research only and is not approved for human use; it should be avoided outside controlled research environments and is typically not used in pregnancy, breastfeeding or by individuals without scientific oversight.
Lab Testing / Quality:
CJC‑1295/Ipamorelin research peptides are supplied as high‑purity lyophilized powder (≥99% purity) with analytical verification (e.g., HPLC/COA) to ensure reproducibility and consistency in experiments.
Storage:
Unopened lyophilized peptides should be stored in a cool, dry, dark place (e.g., −20 °C); after reconstitution with sterile water, keep refrigerated (2–8 °C) and protect from light and moisture to maintain stability per lab protocol.
1. What is the CJC-1295 / Ipamorelin Blend ?
This blend combines CJC-1295 (No DAC), a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a growth hormone-releasing peptide (GHRP). Together, they are designed to stimulate natural growth hormone production for recovery, muscle support, and anti-aging benefits.
2. How does this peptide blend work?
- CJC-1295 (No DAC) increases the frequency of growth hormone pulses by mimicking natural GHRH.
- Ipamorelin enhances growth hormone release through selective ghrelin receptor activation.
- The combination promotes synergistic GH release, supporting muscle growth, fat metabolism, tissue repair, and overall regeneration.
3. Who is this blend ideal for?
This blend is often explored by:
- Fitness enthusiasts and athletes seeking GH optimization
- Individuals interested in anti-aging and wellness research
- Those recovering from muscle or tissue injury
- Men and women looking for natural growth hormone support
4. How long does it take to see results?
Results vary based on individual response, lifestyle, and dosage. Common observations include:
- Muscle growth and recovery: 4–6 weeks
- Improved energy and sleep quality: 2–4 weeks
- Overall anti-aging benefits: Gradual improvement over consistent use
5. How should the blend be stored?
- Store the unreconstituted powder in a cool, dry place
- Refrigerate after reconstitution
- Avoid heat, moisture, and direct sunlight
